Palomino Laboratories (PALX) Accumulated Expenses (2025)
Palomino Laboratories (PALX) reported Accumulated Expenses of $280771.0 for Q4 2025, down 52.06% sequentially from $585703.0 in Q3 2025.
Palomino Laboratories (PALX) Accumulated Expenses (2025) Analysis & Trends
Palomino Laboratories (PALX) has 1 years of Accumulated Expenses data on file, last reported at $280771.0 in Q4 2025.
- For the quarter ending Q4 2025, Accumulated Expenses changed N/A year-over-year to $280771.0; the trailing twelve-month figure through Dec 2025 stood at $280771.0 (changed N/A YoY), and the FY2025 full-year result was $280771.0, changed N/A from the prior year.
- Accumulated Expenses retreated to $280771.0 in Q4 2025, from $585703.0 in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $585703.0 in Q3 2025 to a low of $280771.0 in Q4 2025.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 280,771.00 |
| Sep 30, 2025 | 585,703.00 |